CorVel Corporation

NasdaqGS:CRVL Rapport sur les actions

Capitalisation boursière : US$5.4b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

CorVel Résultats passés

Passé contrôle des critères 5/6

CorVel a connu une croissance annuelle moyenne de ses bénéfices de 12.5%, tandis que le secteur Healthcare a vu ses bénéfices augmenter de en hausse à 7.1% par an. Les revenus ont augmenté de en hausse à un taux moyen de 7.6% par an. Le rendement des capitaux propres de CorVel est 29.6% et ses marges nettes sont de 9.6%.

Informations clés

12.5%

Taux de croissance des bénéfices

14.3%

Taux de croissance du BPA

Healthcare Croissance de l'industrie8.5%
Taux de croissance des recettes7.6%
Rendement des fonds propres29.6%
Marge nette9.6%
Dernière mise à jour des bénéfices30 Jun 2024

Mises à jour récentes des performances passées

Recent updates

Shareholders Are Optimistic That CorVel (NASDAQ:CRVL) Will Multiply In Value

Jul 30
Shareholders Are Optimistic That CorVel (NASDAQ:CRVL) Will Multiply In Value

CorVel Corporation's (NASDAQ:CRVL) Popularity With Investors Is Clear

Jul 12
CorVel Corporation's (NASDAQ:CRVL) Popularity With Investors Is Clear

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Apr 25
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

CorVel Corporation's (NASDAQ:CRVL) Share Price Matching Investor Opinion

Apr 07
CorVel Corporation's (NASDAQ:CRVL) Share Price Matching Investor Opinion

Is Now The Time To Put CorVel (NASDAQ:CRVL) On Your Watchlist?

Mar 19
Is Now The Time To Put CorVel (NASDAQ:CRVL) On Your Watchlist?

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Jan 10
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

The Price Is Right For CorVel Corporation (NASDAQ:CRVL)

Dec 23
The Price Is Right For CorVel Corporation (NASDAQ:CRVL)

With EPS Growth And More, CorVel (NASDAQ:CRVL) Makes An Interesting Case

Dec 05
With EPS Growth And More, CorVel (NASDAQ:CRVL) Makes An Interesting Case

CorVel (NASDAQ:CRVL) Is Investing Its Capital With Increasing Efficiency

Oct 10
CorVel (NASDAQ:CRVL) Is Investing Its Capital With Increasing Efficiency

Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

Sep 01
Here's Why We Think CorVel (NASDAQ:CRVL) Is Well Worth Watching

We Think CorVel (NASDAQ:CRVL) Might Have The DNA Of A Multi-Bagger

Jul 10
We Think CorVel (NASDAQ:CRVL) Might Have The DNA Of A Multi-Bagger

CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

Apr 11
CorVel (NASDAQ:CRVL) Is Very Good At Capital Allocation

If EPS Growth Is Important To You, CorVel (NASDAQ:CRVL) Presents An Opportunity

Mar 24
If EPS Growth Is Important To You, CorVel (NASDAQ:CRVL) Presents An Opportunity

A Look Into CorVel's (NASDAQ:CRVL) Impressive Returns On Capital

Jan 06
A Look Into CorVel's (NASDAQ:CRVL) Impressive Returns On Capital

Should You Be Adding CorVel (NASDAQ:CRVL) To Your Watchlist Today?

Dec 19
Should You Be Adding CorVel (NASDAQ:CRVL) To Your Watchlist Today?

CorVel (NASDAQ:CRVL) Looks To Prolong Its Impressive Returns

Sep 21
CorVel (NASDAQ:CRVL) Looks To Prolong Its Impressive Returns

We Ran A Stock Scan For Earnings Growth And CorVel (NASDAQ:CRVL) Passed With Ease

Aug 25
We Ran A Stock Scan For Earnings Growth And CorVel (NASDAQ:CRVL) Passed With Ease

CorVel GAAP EPS of $0.94, revenue of $176M

Aug 02

Many Would Be Envious Of CorVel's (NASDAQ:CRVL) Excellent Returns On Capital

Jun 23
Many Would Be Envious Of CorVel's (NASDAQ:CRVL) Excellent Returns On Capital

Here's Why I Think CorVel (NASDAQ:CRVL) Is An Interesting Stock

May 18
Here's Why I Think CorVel (NASDAQ:CRVL) Is An Interesting Stock

CorVel (NASDAQ:CRVL) Knows How To Allocate Capital

Mar 21
CorVel (NASDAQ:CRVL) Knows How To Allocate Capital

With EPS Growth And More, CorVel (NASDAQ:CRVL) Is Interesting

Feb 14
With EPS Growth And More, CorVel (NASDAQ:CRVL) Is Interesting

Ventilation des recettes et des dépenses

Comment CorVel gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

NasdaqGS:CRVL Recettes, dépenses et bénéfices (USD Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 2481778800
31 Mar 2479576770
31 Dec 2377475750
30 Sep 2375175730
30 Jun 2373369710
31 Mar 2371966740
31 Dec 2270468710
30 Sep 2269065710
30 Jun 2267066700
31 Mar 2264666680
31 Dec 2162062670
30 Sep 2159759670
30 Jun 2157655660
31 Mar 2155346640
31 Dec 2055443640
30 Sep 2056141640
30 Jun 2057242650
31 Mar 2059247650
31 Dec 1959647660
30 Sep 1959448650
30 Jun 1959548630
31 Mar 1959647630
31 Dec 1858844620
30 Sep 1858343620
30 Jun 1857139610
31 Mar 1855836590
31 Dec 1754835590
30 Sep 1753632570
30 Jun 1752831580
31 Mar 1751929570
31 Dec 1651328580
30 Sep 1650928580
30 Jun 1650529570
31 Mar 1650429580
31 Dec 1549727560
30 Sep 1549628560
30 Jun 1549527550
31 Mar 1549329540
31 Dec 1449131540
30 Sep 1448933540
30 Jun 1448534530
31 Mar 1447934520
31 Dec 1347134500
30 Sep 1345731490

Des revenus de qualité: CRVL a des bénéfices de haute qualité.

Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de CRVL (9.6%) sont supérieures à celles de l'année dernière (9.5%).


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: Les bénéfices de CRVL ont augmenté de 12.5% par an au cours des 5 dernières années.

Accélération de la croissance: La croissance des bénéfices de CRVL au cours de l'année écoulée ( 12.3% ) est inférieure à sa moyenne sur 5 ans ( 12.5% par an).

Bénéfices par rapport au secteur d'activité: La croissance des bénéfices CRVL au cours de l'année écoulée ( 12.3% ) a dépassé celle du secteur Healthcare 6%.


Rendement des fonds propres

ROE élevé: Le retour sur capitaux propres de CRVL ( 29.6% ) est considéré comme élevé.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé